These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 27376595

  • 1. "It's not if I get cancer, it's when I get cancer": BRCA-positive patients' (un)certain health experiences regarding hereditary breast and ovarian cancer risk.
    Dean M.
    Soc Sci Med; 2016 Aug; 163():21-7. PubMed ID: 27376595
    [Abstract] [Full Text] [Related]

  • 2. Previvors' Uncertainty Management Strategies for Hereditary Breast and Ovarian Cancer.
    Dean M, Davidson LG.
    Health Commun; 2018 Feb; 33(2):122-130. PubMed ID: 27976925
    [Abstract] [Full Text] [Related]

  • 3. Maximising survival: the main concern of women with hereditary breast and ovarian cancer who undergo genetic testing for BRCA1/2.
    Jeffers L, Morrison PJ, McCaughan E, Fitzsimons D.
    Eur J Oncol Nurs; 2014 Aug; 18(4):411-8. PubMed ID: 24731853
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience.
    Bakos AD, Hutson SP, Loud JT, Peters JA, Giusti RM, Greene MH.
    Health Expect; 2008 Sep; 11(3):220-31. PubMed ID: 18816319
    [Abstract] [Full Text] [Related]

  • 6. Conditions and consequences of a BRCA mutation in young, single women of childbearing age.
    Hamilton R, Hurley KE.
    Oncol Nurs Forum; 2010 Sep; 37(5):627-34. PubMed ID: 20797954
    [Abstract] [Full Text] [Related]

  • 7. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
    Katapodi MC, Northouse L, Pierce P, Milliron KJ, Liu G, Merajver SD.
    Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
    [Abstract] [Full Text] [Related]

  • 8. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA, U.S. Preventive Services Task Force.
    Ann Intern Med; 2014 Feb 18; 160(4):271-81. PubMed ID: 24366376
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Five families living with hereditary breast and ovarian cancer risk.
    Norris J, Spelic SS, Snyder C, Tinley S.
    Clin J Oncol Nurs; 2009 Feb 18; 13(1):73-80. PubMed ID: 19193551
    [Abstract] [Full Text] [Related]

  • 13. [Cognitive, emotional and behavioral impact of an uncertain outcome after study of BRCA1/2: review of the literature].
    Leblond D, Brédart A, Dolbeault S, De Pauw A, Stoppa Lyonnet D, Flahault C, Sultan S.
    Bull Cancer; 2011 Feb 18; 98(2):184-98. PubMed ID: 21382771
    [Abstract] [Full Text] [Related]

  • 14. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ, Synder C, Bewtra C, Narod SA, Watson P, Lynch HT.
    Gynecol Oncol; 2005 May 18; 97(2):457-67. PubMed ID: 15863145
    [Abstract] [Full Text] [Related]

  • 15. Issues of concern in risk assessment, genetic counseling, and genetic testing of younger breast cancer patients in Japan.
    Bando H.
    Breast Cancer; 2014 Nov 18; 21(6):656-63. PubMed ID: 23754181
    [Abstract] [Full Text] [Related]

  • 16. Cancer risk management decision making for BRCA+ women.
    Leonarczyk TJ, Mawn BE.
    West J Nurs Res; 2015 Jan 18; 37(1):66-84. PubMed ID: 24470135
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Communication of BRCA results and family testing in 1,103 high-risk women.
    Cheung EL, Olson AD, Yu TM, Han PZ, Beattie MS.
    Cancer Epidemiol Biomarkers Prev; 2010 Sep 18; 19(9):2211-9. PubMed ID: 20699375
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.